C.H.U. de Montpellier Trials

C.H.U. de Montpellier	Welcome, Profile Billing Logout

C.H.U. de Montpellier

Welcome, Profile Billing Logout

10 Trials

2 Trials

Active Trials Industry lead sponsorIndustry collaborator

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Makinson, Alain

VOGUE, NCT05979311: A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy

Recruiting

412

Europe, Japan, RoW

Dolutegravir, Lamivudine, Bictegravir, Emtricitabine, Tenofovir alafenamide

ViiV Healthcare

HIV, HIV Infections

11/25

10/26

DORASPEP, NCT05761509: "Observational Study on Tolerability and Observance of Post-exposure Prophylaxis With Doravirine in HIV Viral Risk"

Completed

N/A

226

Europe

Doravirine, Delstrigo®, Pifeltro®

Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba, Merck Sharp & Dohme LLC

HIV Infections

06/24

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites